Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase II study of the EORTC Gynaecological Cancer Cooperative Group.
暂无分享,去创建一个
O. Dalesio | M. Nooij | J. Vermorken | W W ten Bokkel Huinnink | J. Guastalla | J. Wils | M. George | J. Renard | W. W. ten Bokkel Huinnink | V. Scotto
[1] M. Piver,et al. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Howell Sb. Intraperitoneal chemotherapy: the use of concurrent systemic neutralizing agents. , 1985 .
[3] Dedrick Rl. Theoretical and experimental bases of intraperitoneal chemotherapy. , 1985 .
[4] D. Alberts,et al. Intraperitoneal chemotherapy: technical experience at five institutions. , 1985, Seminars in oncology.
[5] Morgan Lr. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients. , 1985 .
[6] J. Neijt,et al. RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA , 1984, The Lancet.
[7] N. Hacker,et al. Pharmacokinetics of Ip cisplatin in refractory ovarian carcinoma. , 1983, Cancer treatment reports.
[8] R. Olshen,et al. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. , 1983, Cancer research.
[9] R. Olshen,et al. Intraperitoneal cisplatin with systemic thiosulfate protection. , 1982, Annals of internal medicine.
[10] P. Sugarbaker,et al. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. , 1981, Cancer research.
[11] V. Devita,et al. High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer. , 1981, Cancer research.